Keyur Parikh
Keyur Parikh
Care Institute of Medical Sciences
Verified email at
Cited by
Cited by
Platelet inhibition with cangrelor in patients undergoing PCI
RA Harrington, GW Stone, S McNulty, HD White, AM Lincoff, CM Gibson, ...
New England Journal of Medicine 361 (24), 2318-2329, 2009
Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial
S James, A Budaj, P Aylward, KK Buck, CP Cannon, JH Cornel, ...
Circulation 122 (11), 1056-1067, 2010
Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial
ZC Jing, K Parikh, T Pulido, C Jerjes-Sanchez, RJ White, R Allen, ...
Circulation 127 (5), 624-633, 2013
Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial
J Hiremath, S Thanikachalam, K Parikh, S Shanmugasundaram, ...
The Journal of heart and lung transplantation 29 (2), 137-149, 2010
Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label …
E Camenzind, W Wijns, L Mauri, V Kurowski, K Parikh, R Gao, C Bode, ...
The Lancet 380 (9851), 1396-1405, 2012
Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris: a prospective, open-label, multicenter, safety feasibility first-in-man study
S Banai, S Ben Muvhar, KH Parikh, A Medina, H Sievert, A Seth, J Tsehori, ...
Journal of the American College of Cardiology 49 (17), 1783-1789, 2007
Safety and feasibility of orbital atherectomy for the treatment of calcified coronary lesions: the ORBIT I trial
K Parikh, P Chandra, N Choksi, P Khanna, J Chambers
Catheterization and Cardiovascular Interventions 81 (7), 1134-1139, 2013
Systematic primary aspiration in acute myocardial percutaneous intervention: a multicentre randomised controlled trial of the export aspiration catheter.
B Chevalier, M Gilard, I Lang, P Commeau, J Roosen, M Hanssen, ...
EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2008
Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT …
W Wijns, PG Steg, L Mauri, V Kurowski, K Parikh, R Gao, C Bode, ...
European heart journal 35 (40), 2812-2820, 2014
Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type
E Camenzind, E Boersma, W Wijns, L Mauri, T Rademaker-Havinga, ...
European heart journal 35 (29), 1932-1948, 2014
Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): randomized controlled trial comparing the incidence of stent …
E Camenzind, W Wijns, L Mauri, E Boersma, K Parikh, V Kurowski, R Gao, ...
American heart journal 158 (6), 902-909. e5, 2009
Wireless acoustic communication with a miniature pressure sensor in the pulmonary artery for disease surveillance and therapy of patients with congestive heart failure
Y Rozenman, RS Schwartz, H Shah, KH Parikh
Journal of the American College of Cardiology 49 (7), 784-789, 2007
Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning
KH Parikh, MC Chag, KJ Shah, UG Shah, HA Baxi, AH Chandarana, ...
Canadian journal of physiology and pharmacology 85 (3-4), 476-482, 2007
Cangrelor with and without glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention
M Vaduganathan, RA Harrington, GW Stone, EN Deliargyris, PG Steg, ...
Journal of the American College of Cardiology 69 (2), 176-185, 2017
Effect of diltiazem on renal clearance and serum concentration of digoxin in patients with cardiac disease
U Elkayam, K Parikh, B Torkan, L Weber, JL Cohen, SH Rahimtoola
The American journal of cardiology 55 (11), 1393-1395, 1985
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED‐HF)
JJV McMurray, IS Anand, R Diaz, AP Maggioni, C O'Connor, MA Pfeffer, ...
European journal of heart failure 15 (3), 334-341, 2013
Orbital atherectomy system in treating calcified coronary lesions: 3-year follow-up in first human use study (ORBIT I trial)
P Bhatt, P Parikh, A Patel, M Chag, A Chandarana, R Parikh, K Parikh
Cardiovascular Revascularization Medicine 15 (4), 204-208, 2014
Long-term safety and performance of the orbital atherectomy system for treating calcified coronary artery lesions: 5-Year follow-up in the ORBIT I trial
P Bhatt, P Parikh, A Patel, M Chag, A Chandarana, R Parikh, K Parikh
Cardiovascular Revascularization Medicine 16 (4), 213-216, 2015
Extended follow‐up safety and effectiveness of the Endeavor zotarolimus‐eluting stent in real‐world clinical practice: Two‐year follow‐up from the E‐Five Registry
I Meredith, M Rothman, A Erglis, K Parikh, C Lotan, E‐Five Investigators
Catheterization and Cardiovascular Interventions 77 (7), 993-1000, 2011
Long-Term follow-up to evaluate the safety of the NEOVASC reducer a DEVICE-BASED therapy for chronic refractory angina
S Banai, M Schwartz, H Sievert, A Seth, G Keren, KH Parikh
Journal of the American College of Cardiology 55 (10S), A98. E927-A98. E927, 2010
The system can't perform the operation now. Try again later.
Articles 1–20